OfficeHours

OCTOBER 16, 2023

First, private equity identifies the publicly traded company they believe is undervalued or could perform better as a private entity without the pressures of being a public entity (e.g. Once the terms are agreed upon, the acquisition is financed through a combination of debt and equity from the PE firm, as with a typical transaction.

Investors 100

Investors Private Equity Equities Debt 100

OfficeHours

OCTOBER 23, 2023

First, private equity identifies the publicly traded company they believe is undervalued or could perform better as a private entity without the pressures of being a public entity (e.g. After the acquisition, the previously public company is delisted from its stock exchange, whether the NYSE, NASDAQ, etc.

Investors 130

Investors Private Equity Equities Debt 130

OfficeHours

AUGUST 20, 2023

Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). The good news is that there are many transferable skills from investment banking (and other non-traditional finance roles) to private equity.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

Focus Investment Banking

JANUARY 18, 2024

There are only a few publicly traded companies in specialty consulting. But those companies have been public for more than 20 years. While the company generated over $260 million in revenues through the first three quarters of 2023, its stock price is trading under a dollar a share, as the company is burdened with substantial debt.

IPO 52

IPO Consulting Corporate Finance Professional Services 52

Cooley M&A

JANUARY 19, 2023

The Inflation Reduction Act imposes a 1% excise tax on certain repurchases of stock of publicly traded US corporations (“Covered Corporations”) effected after December 31, 2022 (the “Excise Tax”). [1] The Notice does not extend the netting rule to deSPAC transactions where target shareholders do not receive SPAC stock (e.g.,

M&A 52

M&A Capital Market Stock Mergers and Acquisitions 52

Intrepid Banker Insights

MARCH 28, 2023

The M&A markets became significantly more challenged in the second half of 2022, and deal activity reported by investment bankers and private equity financial buyers has slowed down, with uncertainty and rising financing costs playing prominent roles. Watching for employee turnover is another key piece of the puzzle.

Capital 52

Capital Advisory Bank Banking 52

Wall Street Mojo

FEBRUARY 9, 2024

The primary sources of LMM companies are primarily different forms of debt and credit line lending systems. When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. The classification helps investors gauge the performance and growth potential to make future investments.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

RKJ Partners

AUGUST 6, 2017

Essentially, comparable company analysis looks at the value of publicly traded companies. The method assumes leveraging, whereby the cash flow of the company is used to pay-off the debt—ultimately building equity. As a result, the value of the company lies in its ability to repay the debt.

M&A 40

M&A Valuation Mergers and Acquisitions Discounted Cash Flow 40

Cooley M&A

MARCH 1, 2019

Capital intensive businesses will also need to consider the prospective implications of any M&A transaction under their financing facilities, including potential changes to their credit ratings, so it will be necessary to socialize the transaction with lenders ahead of time. Is the objective to achieve a partial or complete exit?

IPO 52

IPO Valuation M&A Business 52

Cooley M&A

JANUARY 25, 2023

Will 2023 see a resurgence of traditional public M&A deals or will macro factors and the looming threat of regulatory review continue to push biotechnology companies down creative paths? Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52